CMR Imaging Predicts Death and Other Adverse Events in Suspected Cardiac Sarcoidosis
Simon Greulich,Claudia C. Deluigi,Steffen Gloekler,Andreas Wahl,Christine S. Zürn,Ulrich Kramer,Detlev Nothnagel,Helmut Bültel,Julia Schumm,Stefan Grün,Peter Ong,Anja Wagner,Steffen Schneider,Kai Nassenstein,Meinrad Gawaz,Udo Sechtem,Oliver Bruder,Heiko Mahrholdt +17 more
Reads0
Chats0
TLDR
Among the population of sarcoid patients with nonspecific symptoms, the presence of myocardial scar indicated by LGE was the best independent predictor of potentially lethal events, as well as other adverse events, yielding a Cox HR of 31.6 and of 33.9.Abstract:
Objectives This study aimed to demonstrate that the presence of late gadolinium enhancement (LGE) is a predictor of death and other adverse events in patients with suspected cardiac sarcoidosis. Background Cardiac sarcoidosis is the most important cause of patient mortality in systemic sarcoidosis, yielding a 5-year mortality rate between 25% and 66% despite immunosuppressive treatment. Other groups have shown that LGE may hold promise in predicting future adverse events in this patient group. Methods We included 155 consecutive patients with systemic sarcoidosis who underwent cardiac magnetic resonance (CMR) for workup of suspected cardiac sarcoid involvement. The median follow-up time was 2.6 years. Primary endpoints were death, aborted sudden cardiac death, and appropriate implantable cardioverter-defibrillator (ICD) discharge. Secondary endpoints were ventricular tachycardia (VT) and nonsustained VT. Results LGE was present in 39 patients (25.5%). The presence of LGE yields a Cox hazard ratio (HR) of 31.6 for death, aborted sudden cardiac death, or appropriate ICD discharge, and of 33.9 for any event. This is superior to functional or clinical parameters such as left ventricular (LV) ejection fraction (EF), LV end-diastolic volume, or presentation as heart failure, yielding HRs between 0.99 (per % increase LVEF) and 1.004 (presentation as heart failure), and between 0.94 and 1.2 for potentially lethal or other adverse events, respectively. Except for 1 patient dying from pulmonary infection, no patient without LGE died or experienced any event during follow-up, even if the LV was enlarged and the LVEF severely impaired. Conclusions Among our population of sarcoid patients with nonspecific symptoms, the presence of myocardial scar indicated by LGE was the best independent predictor of potentially lethal events, as well as other adverse events, yielding a Cox HR of 31.6 and of 33.9, respectively. These data support the necessity for future large, longitudinal follow-up studies to definitely establish LGE as an independent predictor of cardiac death in sarcoidosis, as well as to evaluate the incremental prognostic value of additional parameters.read more
Citations
More filters
Journal ArticleDOI
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Sana M. Al-Khatib,William G. Stevenson,Michael J. Ackerman,William J. Bryant,David J. Callans,Anne B. Curtis,Barbara J. Deal,Timm Dickfeld,Michael E. Field,Gregg C. Fonarow,Anne M. Gillis,Christopher B. Granger,Stephen C. Hammill,Mark A. Hlatky,Jose A. Joglar,G. Neal Kay,Daniel D. Matlock,Robert J. Myerburg,Richard L. Page +18 more
TL;DR: The next chair and vice-chair will be announced at a special meeting of the American Academy of Anti-Accident and Accident Medicine (AACC) board of directors in New York later this month.
Journal ArticleDOI
Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations.
Vanessa M Ferreira,Jeanette Schulz-Menger,Godtfred Holmvang,Christopher M. Kramer,Iacopo Carbone,Udo Sechtem,Ingrid Kindermann,Matthias Gutberlet,Leslie T. Cooper,Peter Liu,Matthias G. Friedrich +10 more
TL;DR: This JACC Scientific Expert Panel provides consensus recommendations for an update of the cardiovascular magnetic resonance (CMR) diagnostic criteria for myocardial inflammation in patients with suspected acute or active myocardian inflammation (Lake Louise Criteria) that include options to use parametric mapping techniques.
Journal ArticleDOI
HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis
David H. Birnie,William H. Sauer,Frank Bogun,Joshua M. Cooper,Daniel A. Culver,Claire S. Duvernoy,Marc A. Judson,Jordana Kron,Davendra Mehta,Jens Cosedis Nielsen,Amit R. Patel,Tohru Ohe,Pekka Raatikainen,Kyoko Soejima +13 more
TL;DR: This research presents a meta-anatomy of the autonomic nervous system, a probabilistic model of how the immune system regulates emotion, language, and physical activity in relation to heart disease.
Journal ArticleDOI
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Paul A. Heidenreich,Biykem Bozkurt,David Aguilar,Larry A. Allen,Joni J. Byun,Monica Colvin,Anita Deswal,Mark H. Drazner,Shannon M. Dunlay,Linda R. Evers,James C. Fang,Savitri Fedson,Gregg C. Fonarow,Salim S. Hayek,Adrian F. Hernandez,Prateeti Khazanie,Michelle M. Kittleson,Christopher S. Lee,Mark S. Link,Carmelo A. Milano,Lorraine C. Nnacheta,Alexander T. Sandhu,Lynne W. Stevenson,Orly Vardeny,Amanda R. Vest,Clyde W. Yancy +25 more
TL;DR: The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" as discussed by the authors provides patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure.
Journal ArticleDOI
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Fred M. Kusumoto,Mark H. Schoenfeld,Coletta Barrett,James R. Edgerton,Kenneth A. Ellenbogen,Michael R. Gold,Nora Goldschlager,Robert M. Hamilton,Jose A. Joglar,Robert Kim,Richard T. Lee,Joseph E. Marine,Christopher J. McLeod,Keith R. Oken,Kristen K. Patton,Cara N. Pellegrini,Kimberly A. Selzman,Annemarie Thompson,Paul D. Varosy +18 more
TL;DR: The next generation of scientists and decision-makers will be shaped by the experiences of those who have gone before them and will help shape the future of medicine and science.
References
More filters
Journal ArticleDOI
Amiodarone or an implantable cardioverter-defibrillator for congestive Heart failure
Gust H. Bardy,Kerry L. Lee,Daniel B. Mark,Jeanne E. Poole,Douglas L. Packer,Robin Boineau,Michael J. Domanski,Charles Troutman,Jill Anderson,Steven McNulty,Nancy E. Clapp-Channing,Linda Davidson-Ray,Elizabeth S. Fraulo,Daniel P. Fishbein,Richard M. Luceri,John Ip +15 more
TL;DR: In patients with NYHA class II or III CHF and LVEF of 35 percent or less, amiodarone has no favorable effect on survival, whereas single-lead, shock-only ICD therapy reduces overall mortality by 23 percent.
Journal ArticleDOI
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Andrew E. Epstein,John P. DiMarco,Kenneth A. Ellenbogen,N.A. Mark Estes,Roger A. Freedman,Leonard S. Gettes,A. Marc Gillinov,Gabriel Gregoratos,Stephen C. Hammill,David L. Hayes,Mark A. Hlatky,L. Kristin Newby,Richard L. Page,Mark H. Schoenfeld,Michael J. Silka,Lynne W. Stevenson,Michael O. Sweeney +16 more
TL;DR: Sidney C. Smith, Jr,MD, FACC, FAHA, Chair Alice K. Jacobs, MD, F ACC,FAHA, Vice-Chair Cynthia D. Adams, RN, PhD, FAH.
Journal ArticleDOI
An Improved MR Imaging Technique for the Visualization of Myocardial Infarction
Orlando P. Simonetti,Raymond J. Kim,David S. Fieno,H. B. Hillenbrand,Edwin Wu,Jeffrey M. Bundy,J P Finn,Robert M. Judd +7 more
TL;DR: The segmented inversion-recovery turboFLASH sequence produced the greatest differences in regional myocardial signal intensity in animals and patients and substantially improved differentiation between injured and normal regions.
Journal ArticleDOI
Cardiovascular Magnetic Resonance Assessment of Human Myocarditis: A Comparison to Histology and Molecular Pathology
Heiko Mahrholdt,Christine Goedecke,Anja Wagner,Gabriel Meinhardt,Anasthasios Athanasiadis,Holger Vogelsberg,Peter Fritz,Karin Klingel,Reinhard Kandolf,Udo Sechtem +9 more
TL;DR: Contrast enhancement is a frequent finding in the clinical setting of suspected myocarditis and is associated with active inflammation defined by histopathology and is a valuable tool for the evaluation and monitoring of inflammatory heart disease.
Journal ArticleDOI
Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis
Heiko Mahrholdt,Anja Wagner,Claudia C. Deluigi,Eva Maria Kispert,Stefan Hager,Gabriel Meinhardt,Holger Vogelsberg,Peter Fritz,Juergen Dippon,C.-Thomas Bock,Karin Klingel,Reinhard Kandolf,Udo Sechtem +12 more
TL;DR: The data indicate that PVB19 and HHV6 are the most important causes for viral myocarditis in Germany and that the clinical presentation is related to the type of virus.